Table 4 Cross-lagged longitudinal multivariable analyses of F2-isoprostanes and carotenoids with depressive symptoms (CES-D)a

From: Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms: results from the CARDIA study

CARDIA exam years 10, 15 and 20

Model 1

Model 2

Model 3

Independent variable

Dependent variable

Adjusted for

Age, sex, race, education

Age, sex, race, education, somatic disease, supplement use

Age, sex, race, education, somatic disease, supplement use, diet, BMI, smoking, alcohol, physical activity

   

N

β

P

N

β

P

N

β

P

F2-isoprostanes

 CES-Db

F2-isoprostanes 5 years later

Previous F2-isoprostane levels

2334

0.06

0.001

2321

0.05

0.002

2304

0.03

0.064

 CES-D16b

F2-isoprostanes 5 years later

Previous F2-isoprostane levels

2334

0.05

0.003

2321

0.05

0.004

2304

0.03

0.048

 CES-D16 and/or ADb

F2-isoprostanes 5 years later

Previous F2-isoprostane levels

2334

0.06

<0.001

2321

0.06

0.001

2304

0.04

0.012

 F2-isoprostanesc

CES-D 5 years later

Previous CES-D scores

2589

0.04

0.028

2576

0.04

0.028

2506

0.03

0.095

Sum of five carotenoids d

 CES-De

Sum of five carotenoids 5 years later

Previous carotenoid levels

2356

−0.07

<0.001

2347

−0.07

<0.001

2306

−0.05

0.004

 CES-D16e

Sum of five carotenoids 5 years later

Previous carotenoid levels

2356

−0.06

<0.001

2347

−0.06

<0.001

2306

−0.05

0.002

 CES-D16 and/or ADe

Sum of five carotenoids 5 years later

Previous carotenoid levels

2356

−0.06

<0.001

2347

−0.06

<0.001

2306

−0.05

0.004

 Sum of five carotenoidsf

CES-D 5 years later

Previous CES-D scores

2504

−0.03

0.069

2492

−0.03

0.086

2476

−0.01

0.560

  1. Abbreviations: AD, antidepressant; BMI, body mass index; CARDIA, Coronary Artery Risk Development in Young Adults; CES-D, Center for Epidemiologic Studies Depression Scale; N, number.
  2. aF2-isoprostanes and carotenoids log-transformed for linear regression analysis. Results are reported as standardized regression coefficients. All the results are adjusted for CENTER at baseline.
  3. bCES-D at year 15, F2-isoprostanes at year 20, covariates at year 15; adjusted for F2-isoprostanes at year 15.
  4. cF2-isoprostanes at year 15, CES-D at year 20, covariates at year 15; adjusted for CES-D scores at year 15.
  5. dSum of standardized (t-scores) zeaxanthin/lutein, β-cryptoxanthin, lycopene, α-carotene, β-carotene.
  6. eCES-D at year 10, sum of five carotenoids at year 15, covariates at year 10; adjusted for carotenoids at year 7 (as there are no data on carotenoids available in year 10 (see Figure 1)).
  7. fSum of five carotenoids at year 15, CES-D at year 20, covariates at year 15; adjusted for CES-D scores at year 15.